in Medical Technology

  • Cardiovascular Medtech
  • Diagnostic and Therapeutic Devices
  • Medtech Data Analytics
  • Nano-Based Drug Delivery
  • Pharmaceutical Innovation
  • Regenerative Technologies
  • Regulatory Affairs

Submit your manuscript

  • (current)Section
  • About
  • Articles
  • Research topics
  • For authors
    • Why submit?
    • Fees
    • Article types
    • Author guidelines
    • Review guidelines
    • Submission checklist
    • Contact editorial office
    • Submit your manuscript
  • Editorial board
  • Article alerts

Articles

  • Online articles
  • Latest
  • Most viewed
Loading..

Scope

Frontiers in Medical Technology specialty section Regulatory Affairs aims to bridge the gap between the regulatory requirements for the registration of medicines, combination products and medical devices, Health Technology Assessment and reimbursement. In the last decade there has been an effort to better align such requirements for efficacy, effectiveness, cost-effectiveness, benefits, toxicity and safety. Regulatory Affairs welcomes papers on both regulatory issues relating to new medical technologies as well as Health Technology Assessment.

Editorial Board

  •  

This section has no chief editors.

Loading..

Research Topics

  •  

Loading..
  • Specialty Chief Editors
  • Scope
  • Facts
  • Submission
  • Open Access Statement
  • Copyright Statement
  • Quality
  • Contact

Scope

Frontiers specialty section Regulatory Affairs aims to bridge the gap between the  regulatory requirements for the registration of medicines, combination products and medical devices, Health Technology Assessment and reimbursement. In the last decade there has been an effort to better align such requirements for efficacy, effectiveness, cost-effectiveness, benefits, toxicity and safety. Regulatory Affairs welcomes papers on both regulatory issues relating to new medical technologies as well as Health Technology Assessment. Topics may concern the whole spectra of trial design to real-world evidence, the use of intermediate to final endpoints, quality-of-life estimation to costing, numbers needed to treat to cost per quality-adjusted life-year and benefit/harm to cost-utility analysis.

Requirements for market authorizations and reimbursements all face specific and common challenges, both for conventional medicines as well as test, aids and appliances and new highly-specialized technologies, such as cell and gene therapies, medicines for ultra-rare diseases, new classes of vaccines, immunotherapies and others. Papers on all these issues are also welcomed, both applied and methodological.

Alongside practical issues for regulation, Regulatory Affairs aims to enhance methodologies and related discussions. These can be in the areas of survival analysis, extrapolations, propensity scoring, quality of life-measurement, cost-effectiveness analysis, probabilistic and uncertainty analyses, ethical philosophies and economic theories. Overall, Regulatory Affairs aims to bring the worlds of technologies' marketing authorization and technologies’ reimbursement closer together, ultimately benefiting the patients with rapidly available, effective, safe, affordable and cost-effective treatments within sustainable health-care systems.

Facts

Indexed in: Google Scholar, DOAJ, CrossRef, CLOCKSS

PMCID: NA

Submission

Regulatory Affairs welcomes submissions of the following article types: Brief Research Report, Case Report, Classification, Clinical Trial, Community Case Study, Correction, Curriculum, Instruction, and Pedagogy, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Policy and Practice Reviews, Policy Brief, Review, Specialty Grand Challenge, Study Protocol, Systematic Review and Technology and Code.

All manuscripts must be submitted directly to the section Regulatory Affairs, where they are peer-reviewed by the Associate and Review Editors of the specialty section.

Open Access Statement

Copyright Statement

Quality

Contact

Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01

medicaltechnology.editorial.office@frontiersin.org

Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org

    • All Roles
    • Specialty Chief Editors
    • Associate Editors
    • Review Editors
  • Editor(s) found
  • By role
  • Most viewed
  • Most publications

There are no results to display.

Loading..

Click on any of the keywords to find further editors related to it.
    • Article(s) found
    • Latest
    • Most viewed
    Loading..

    This section has no articles.

    There are no articles to display. Please try changing the filters.

      • All stages
      • Submission open
      • Submission closed
      • Ebook available
    • Research Topic(s) found
    • Latest
    • Most viewed

    Loading..

    Loading..

    Loading..

    Loading..

    Loading..

    Loading..

    Loading..

    Contact Editorial Office

    Frontiers Editorial Office

    Avenue du Tribunal Fédéral 34
    CH – 1005 Lausanne
    Switzerland

    Tel +41(0)21 510 17 40
    Fax +41 (0)21 510 17 01

    For all queries regarding manuscripts in Review and potential conflicts of interest, please contact medicaltechnology.editorial.office@frontiersin.org

    For queries regarding Research Topics, Editorial Board applications, and journal development, please contact medicaltechnology@frontiersin.org

    Frontiers IT HelpDesk

    Tel +41(0)21 510 17 10
    Fax +41 (0)21 510 17 01

    For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org

    Loading..